ArticleThe Journal of physiology2025
Functional control of heteromeric Kv2.1/6.4 channels by the voltage sensor domain of the silent Kv6.4 subunit.
Article in The Journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In the activation process of Kv channels, the S4 segment of the voltage-sensing domain (VSD) moves in the outward direction. A conserved phenylalanine in the transmembrane S2 helix of the VSD is viewed as operating as a charge transfer centre (CTC) that interacts with a positively charged arginine of the S4 helix. This phenylalanine is highly sensitive to diverse substitutions. Kv2.1 subunits can form functional homotetrameric channels on their own whereas 'silent' Kv6.4 subunits can only contribute to functional heterotetrameric channels. We used concatenated dimers of Kv2.1 and Kv6.4 subunits to define the stoichiometry and position of these subunits in functional heterotetrameric channels. Our results demonstrate that mutating the phenylalanine F273 of the Kv6.4 subunits in Kv 2.1_6.4 channels built of dimers to diverse other amino acids at the CTC affects steady-state activation only moderately whereas it strongly shifts steady-state inactivation by 40 mV toward more depolarized potentials compared to Kv2.1_6.4 wild-type channels. Mutating the Kv6.4 subunits in this heterotetramer slowed down the recovery from closed-state inactivation without impacting open-state inactivation. Moreover, results with the specific Kv2.1 blocker guangxitoxin suggest that Kv6.4 subunits may partly activate Kv2.1_6.4 channels. It is concluded that F273 in the silent Kv6.4 subunit of Kv2.1_6.4 channels has a unique role in controlling activation and the recovery from inactivation. HIGHLIGHTS: This study quantifies the functional effects of Kv6.4 mutations in Kv2.1_6.4 channels on activation and inactivation. Highly diverse mutations of the phenylalanine in the charge transfer centre of Kv6.4 reveal its unique role in Kv2.1_6.4 channels in closed state inactivation. The specific Kv2.1 blocker guangxitoxin unmasks that Kv6.4 subunits can partly activate Kv2.1_6.4 channels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.